Immune checkpoint inhibitors to treat cutaneous malignancies
Dulce M. Barrios, H. Mytrang, Gregory S. Phillips, Michael A. Postow, Tomoko Akaike, Paul Nghiem, Mario E. Lacouture
Topics & Concepts
MedicineAvelumabNivolumabPembrolizumabIpilimumabMerkel cell carcinomaImmune checkpointImmunotherapyMelanomaOncologyClinical trialImmunologyImmune systemInternal medicineCancer researchCarcinomaPolyomavirus and related diseasesNonmelanoma Skin Cancer StudiesCancer Immunotherapy and Biomarkers